Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats.
D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001578:Benzopyrans / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D007677:Kidney Function Tests; D008297:Male; D000068577:Nebivolol; D009392:Nephrectomy; D018384:Oxidative Stress / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D052096:Warm Ischemia
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol